BirchBioMed
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
130 Kingscross Dr, King City, Ontario, L...Phone Number
(866) 350-1993Website
www.birchbiomed.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About BirchBioMed
BirchBioMed is a clinical-stage biopharmaceutical company focused on developing innovative treatments for organ fibrosis, scarring, and specific autoimmune disorders such as Type 1 Diabetes. Utilizing groundbreaking technologies licensed from the University of British Columbia, the company aims to transform patient care with its advanced therapies. BirchBioMed's product pipeline includes topical creams and systemic therapies centered around Kynurenic Acid, addressing critical healthcare challenges. Their mission is to deliver transformative solutions globally, targeting diseases with high unmet medical needs.Explore more
BirchBioMed Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BirchBioMed your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at BirchBioMed
Funding: Get notified immidiatlly once BirchBioMed has new funding data
Product Launch: Get notified when BirchBioMed launches new products
Click to see if BirchBioMed had a recent Job posting/layoffs
Check out if BirchBioMed is spiking on competitors!
Earning: See what the market has to say on BirchBioMed recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if BirchBioMed has recently received funding, and reach out quickly before it becomes old news!
BirchBioMed, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined BirchBioMed as Masked Content
Find 3 more new buyers
Compare Similar Companies to BirchBioMed
Compare insights from companies similar to BirchBioMed, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BirchBioMed is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BirchBioMed is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BirchBioMed.
BirchBioMed financials insights
Gather financial insights about BirchBioMed, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Debt
$175K
BirchBioMed Tech Stack
A closer look at the technologies used by BirchBioMed
BirchBioMed News & Media
BirchBioMed Receives Health Canada Approval for Topical Cream (NPN 80147114)
The Company's new natural health product promotes treatment and improves appearance of scars, including even severe ones like mature keloid scars VANCOUVER, BC, Feb. 4, 2026 /PRNewswire/ -- BirchBioMed Inc. today announced that following a comprehensive review of the product's safety,...U.S. FDA GRANTS BIRCHBIOMED ORPHAN DRUG DESIGNATION FOR FS2 IN THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
VANCOUVER, BC, Dec. 2, 2025 /PRNewswire/ - BirchBioMed Inc., a leading clinical stage biopharmaceutical company, expert in the development of products for scarring and other fibrosis-related disorders and autoimmune therapeutics, today announced that the U.S. Food and Drug Administration...BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc.
Collaboration Expected to Advance FS2 Topical Platform and Strengthen BGLC’s Biotech Footprint in Asia Collaboration Expected to Advance FS2 Topical Platform and Strengthen BGLC’s Biotech Footprint in Asia
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding BirchBioMed
Sign Up For FreeTo access detailed company insights
BirchBioMed is a clinical-stage biopharmaceutical company focused on developing innovative treatments for organ fibrosis, scarring, and specific autoimmune disorders such as Type 1 Diabetes. Utilizing groundbreaking technologies licensed from the University of British Columbia, the company aims to transform patient care with its advanced therapies.... Read More
